Mr. Weir et al., DIFFERING MECHANISMS OF ACTION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN BLACK-AND-WHITE HYPERTENSIVE PATIENTS, Hypertension, 26(1), 1995, pp. 124-130
The antihypertensive effect of the angiotensin-converting enzyme inhib
itor trandolapril administered in doses of 1, 2, and 4 mg/d was compar
ed in 207 white patients and 91 black patients with mild to moderate h
ypertension following a double-blind, randomized, placebo-controlled,
parallel study design. Trandolapril is a prodrug that is rapidly hydro
lyzed to its active diacid metabolite, trandolaprilat. After 6 weeks o
f double-blind treatment, trandolapril lowered baseline sitting diasto
lic pressure in both white and black patients. A comparison of the ant
ihypertensive response of the two populations revealed that the black
patients required between two and four times the dose of trandolapril
to obtain a response similar to that observed in the white patients. A
dose of 1 mg/d trandolapril resulted in a 6.1 mm Hg mean decrease in
baseline sitting diastolic pressure for white patients; a similar resp
onse (-6.5 mm Hg) was observed in the black patients at 4 mg/d. In con
trast to the population differences in blood pressure, the decreases i
n angiotensin-converting enzyme activity were similar for both populat
ions. An evaluation of trandolaprilat levels revealed that there were
no racial differences in the trandolaprilat concentrations required to
achieve a given degree of angiotensin-converting enzyme inhibition. T
herefore, it appears that the antihypertensive response of black patie
nts is not completely explained by a reduction in angiotensin-converti
ng enzyme activity. The lack of response at a lower dose but increasin
g response at a higher dose could reflect another vasodepressor activi
ty of trandolapril or just be evidence of reduced sensitivity of high
blood pressure in blacks to angiotensin-converting enzyme inhibition.